Volume 1, Issue 3, Fall 2024

View Volume 1, Issue 3, Fall 2024

First-line Treatment Selection for Advanced Hepatocellular Carcinoma
Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer
Breast Cancer Survivorship
Tailored Approaches and Patient-centered Care: The Current Landscape of Neoadjuvant Therapy in Rectal Cancer
Antibody-Drug Conjugates in the Management of Advanced Urothelial Carcinoma

Published: 2024-10-28

Full Issue

Articles

First-line Treatment Selection for Advanced Hepatocellular Carcinoma

Zainab Al Maqrashi, MD, MSc, Brandon M. Meyers, MD, MSc, FRCPC

4–9
- PDF (en)
- PDF (fr)
Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer

Urban Emmenegger, MD, Rubens Sperandio, MD

10–16
- PDF (en)
- PDF (fr)
Breast Cancer Survivorship

Nancy Nixon, MD, FRCPC, Sarah Cook, MD, FRCPC

18–26
- PDF (en)
- PDF (fr)
Tailored Approaches and Patient-centered Care: The Current Landscape of Neoadjuvant Therapy in Rectal Cancer

Tharani Krishnan, MD

28–33
- PDF (en)
- PDF (fr)
Antibody-drug Conjugates in The Management of Advanced Urothelial Carcinoma

Pooya Dibajnia, BSc (Hons), MD, FRCPC, Aly-Khan Lalani, BSc (Hons), MD, FRCPC

34–43
- PDF (en)
- PDF (fr)